Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: A Study of the Natural Progression of Interstitial Lung Disease (ILD)

View source ↗

Summary

An ongoing University of Chicago study aims to characterize the natural progression of interstitial lung diseases. The study includes idiopathic pulmonary fibro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Chicago | Conditions: Interstitial Lung Diseases, Idiopathic Pulmonary Fibrosis | Status: RECRUITING